POLYMORPHISM IN THE BCL2 GENE DETERMINES RESPONSE TO CHEMOTHERAPY

• 收藏
• 分享

专利权人:

发明人:

Sol EFRONI,Alona ZILBERBERG,Rotem BEN-HAMO

申请号：

US15319628

公开号：

US20170152569A1

申请日:

2015.06.18

申请国别(地区):

US

年份:

2017

代理人:

摘要：

Provided are methods useful for determining the expected efficacy of certain chemotherapy treatments and methods of treating cancer based on said determination. In particular, provides are methods and procedures of predicting the efficacy of paclitaxel treatments in cancer patients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/